Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience
Advances in Medicine · 05.06.2018 · 2018 · 1-5
DOI: 10.1155/2018/1473160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Medicine, erschienen am 05.06.2018. Verfasst von Bartłomiej Matejko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolic Diseases, Jagiellonian University Medical College, Kraków, Poland. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Basal insulin (BI) infusion in pump therapy of type 1 diabetes (T1DM) mimics physiological secretion during the night and between meals. The recommended percentage of the total BI to daily insulin dose (termed the %BI) ranges between 30 and 50%. We analyzed whether this recommendation was followed in adults with T1DM from a university center, and whether BI doses were linked with glycemic control. Materials and Methods . We included 260 consecutive patients with T1DM (159 women and 101 men) treated with continuous subcutaneous insulin infusion at the Department of Metabolic Diseases, Krakow, Poland. Data were downloaded from patients’ pumps and collected from medical records. We analyzed the settings of BI and the association of %BI with HbA1c level. Linear regression was performed.
Results
The mean age of T1DM individuals was 26.6 ± 8.2 years, BMI was 23.1 ± 3.0 kg/m 2 , T1DM duration was 13.3 ± 6.4 years, and HbA1c level was 7.4%. There were 69.6% ( n = 181 ) of T1DM patients with %BI in the recommended range. The T1DM duration and HbA1c level of patients with a %BI 50% ( n = 56 ), it was 15.8 years and 7.8% ( p < 0.001 for both three-group comparisons). Multiple regression identified %BI among independent predictors of the HbA1c level.
Conclusion
In this real-life analysis, the recommendations concerning %BI dosing were not followed by almost one-third of adult T1DM patients. Low %BI was associated with better glycemic control; however, this requires further confirmation.
Autor:innen und Institutionen
- Department of Metabolic Diseases, Jagiellonian University Medical College, Kraków, Poland.
- University Hospital, Kraków, Poland.
- Faculty of Electrical Engineering, Automatics, Computer Science and Biomedical Engineering, AGH University of Science and Technology, Kraków, Poland.
ORCID-Profile: Bartłomiej Matejko, Maciej T Malecki
Zitieren
APA
Matejko, B., Kukułka, A., Kieć-Wilk, B., Stąpór, A., Klupa, T., & Malecki, M. T. (2018). Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience. Advances in Medicine, 2018, 1-5. https://doi.org/10.1155/2018/1473160
Vancouver
Matejko B, Kukułka A, Kieć-Wilk B, Stąpór A, Klupa T, Malecki MT. Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience. Advances in Medicine. 2018;2018:1-5. doi:10.1155/2018/1473160
BibTeX
@article{Matejko2018,
author = {Matejko, Bartłomiej and Kukułka, Aneta and Kieć-Wilk, Beata and Stąpór, Agnieszka and Klupa, Tomasz and Malecki, Maciej T},
title = {Basal Insulin Dose in Adults with Type 1 Diabetes Mellitus on Insulin Pumps in Real-Life Clinical Practice: A Single-Center Experience},
journal = {Advances in Medicine},
year = {2018},
volume = {2018},
pages = {1--5},
doi = {10.1155/2018/1473160}
}
EUVIMED